BackIndivior Plc Overview
Indivior Plc

Indivior Plc Target Price

See Indivior Plc's analyst price targets ($47) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$38.73

Average Target Price

$47.3322.2% upside

3 analysts in the last 4 months

High: $53 | Low: $43

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05BarclaysGlen Santangelo$4311% upsideOpen
2026-08-04Craig-HallumChase Knickerbocker$5336.8% upsideOpen
2026-06-18Barclays$4618.8% upsideOpen
2026-01-20Northland Securities$5029.1% upsideOpen
2026-01-12H.C. Wainwright$4823.9% upsideOpen
2025-12-03Morgan Stanley$367% downsideOpen
2025-10-31Craig-Hallum$415.9% upsideOpen
2025-10-31Northland Securities$403.3% upsideOpen
2025-10-30H.C. WainwrightBrandon Folkes$359.6% downsideOpen
2025-08-27Craig-HallumChase Knickerbocker$3412.2% downsideOpen
2025-03-06Piper Sandler$1366.4% downsideOpen
2024-10-11Piper SandlerDavid Amsellem$1561.3% downsideOpen
2024-09-23Craig-HallumChase Knickerbocker$2048.4% downsideOpen
2024-09-13Piper SandlerDavid Amsellem$2243.2% downsideOpen
2024-07-10Craig-HallumChase Knickerbocker$2438% downsideOpen
2024-04-03Craig-HallumChase Knickerbocker$374.5% downsideOpen

Indivior Plc (INDV) FAQ

Indivior Plc's target price stands at $47. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $47 for INDV implies 22.2% upside versus today's price ($38.73). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Indivior Plc's target price evolved across reporting periods, while the comparison chart places INDV next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Indivior Plc's reading of $47 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.